Contact this trialFirst, we need to learn more about you.
Anti-metabolites
NIS793 +/− Spartalizumab + Chemotherapy for Pancreatic Cancer
Recruiting1 awardPhase 2
Pittsburgh, Pennsylvania
This trial is testing a new combination of drugs to treat pancreatic cancer. The goal is to see if it is more effective and has fewer side effects than the current standard of care.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.